FKBP5 polymorphisms induce differential glucocorticoid responsiveness in primary CNS cells - First insights from novel humanized mice.
Fkbp5
CNS cell types
astrocyte
glucocorticoid responsiveness
psychiatric disorders
Journal
The European journal of neuroscience
ISSN: 1460-9568
Titre abrégé: Eur J Neurosci
Pays: France
ID NLM: 8918110
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
13
07
2020
accepted:
22
09
2020
pubmed:
9
10
2020
medline:
29
6
2021
entrez:
8
10
2020
Statut:
ppublish
Résumé
The brain is a central hub for integration of internal and external conditions and, thus, a regulator of the stress response. Glucocorticoids are the essential communicators of this response. Aberrations in glucocorticoid signaling are a common symptom in patients with psychiatric disorders. The gene FKBP5 encodes a chaperone protein that functionally inhibits glucocorticoid signaling and, thus, contributes to the regulation of stress. In the context of childhood trauma, differential expression of FKBP5 has been found in psychiatric patients compared to controls. These variations in expression levels of FKBP5 were reported to be associated with differences in stress responsiveness in human carriers of the single nucleotide polymorphism (SNP) rs1360780. Understanding the mechanisms underlying FKBP5 polymorphism-associated glucocorticoid responsiveness in the CNS will lead to a better understanding of stress regulation or associated pathology. To study these mechanisms, two novel humanized mouse lines were generated. The lines carried either the risk (A/T) allele or the resilient (C/G) allele of rs1360780. Primary cells from CNS (astrocytes, microglia, and neurons) were analyzed for their basal expression levels of FKBP5 and their responsiveness to glucocorticoids. Differential expression of FKBP5 was found for these cell types and negatively correlated with the cellular glucocorticoid responsiveness. Astrocytes revealed the strongest transcriptional response, followed by microglia and neurons. Furthermore, the risk allele (A/T) was associated with greater induction of FKBP5 than the resilience allele. Novel FKBP5-humanized mice display differential glucocorticoid responsiveness due to a single intronic SNP. The vulnerability to stress signaling in the shape of glucocorticoids in the brain correlated with FKBP5 expression levels. The strong responsiveness of astrocytes to glucocorticoids implies astrocytes play a prominent role in the stress response, and in FKBP5-related differences in glucocorticoid signaling. The novel humanized mouse lines will allow for further study of the role that FKBP5 SNPs have in risk and resilience to stress pathology.
Identifiants
pubmed: 33030232
doi: 10.1111/ejn.14999
pmc: PMC7894319
doi:
Substances chimiques
Glucocorticoids
0
Tacrolimus Binding Proteins
EC 5.2.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
402-415Informations de copyright
© 2020 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
Références
Mol Cell. 2014 Mar 20;53(6):941-53
pubmed: 24613341
Alzheimers Res Ther. 2018 Sep 19;10(1):95
pubmed: 30227888
J Neurochem. 1991 Oct;57(4):1422-8
pubmed: 1680166
Brain Behav Immun. 2015 Nov;50:18-30
pubmed: 26256574
Front Behav Neurosci. 2019 Jul 26;13:143
pubmed: 31404254
Neuroscience. 2021 Feb 1;454:151-161
pubmed: 31302265
Glia. 2019 Sep;67(9):1637-1653
pubmed: 31038797
Am J Psychiatry. 2011 Oct;168(10):1107-16
pubmed: 21865530
Int J Biochem Cell Biol. 2017 Apr;85:166-174
pubmed: 28259749
Neuroimmunomodulation. 2017;24(4-5):242-255
pubmed: 29332092
Ann N Y Acad Sci. 2009 Oct;1179:144-52
pubmed: 19906237
Diabetes. 2006 Jul;55(7):2059-66
pubmed: 16804076
J Mol Biol. 2001 May 11;308(4):795-806
pubmed: 11350175
Dev Cogn Neurosci. 2015 Feb;11:18-30
pubmed: 25081071
Neurosci Biobehav Rev. 2010 Sep;35(1):2-16
pubmed: 19822172
Br J Pharmacol. 2020 Sep;177(17):4074
pubmed: 31423567
CNS Neurosci Ther. 2020 Feb;26(2):167-176
pubmed: 31423743
JAMA. 2008 Mar 19;299(11):1291-305
pubmed: 18349090
Int J Mol Sci. 2019 Jun 04;20(11):
pubmed: 31167373
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23280-23285
pubmed: 31399550
Transl Psychiatry. 2018 Nov 28;8(1):255
pubmed: 30487639
Eur J Neurosci. 2008 Jul;28(2):389-98
pubmed: 18702710
J Biol Chem. 2005 Feb 11;280(6):4609-16
pubmed: 15591061
J Neurosci. 2013 Dec 11;33(50):19534-54
pubmed: 24336719
Biol Psychiatry. 2006 Aug 15;60(4):376-82
pubmed: 16919525
Curr Biol. 2019 Sep 23;29(18):3120-3127.e5
pubmed: 31495587
Nat Neurosci. 2013 Jan;16(1):33-41
pubmed: 23201972
J Clin Immunol. 2011 Feb;31(1):122-7
pubmed: 20853021
Int J Mol Sci. 2017 Dec 05;18(12):
pubmed: 29206196
Acta Neuropathol. 2014 Jan;127(1):109-35
pubmed: 24318124
Genomics. 2003 Jun;81(6):640-3
pubmed: 12782134
Curr Opin Pharmacol. 2011 Aug;11(4):326-31
pubmed: 21531172
Transl Psychiatry. 2014 Jun 24;4:e403
pubmed: 24959896
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 4;65:68-77
pubmed: 26320029
Front Cell Neurosci. 2019 Feb 12;13:44
pubmed: 30809131
Hum Genomics. 2017 Dec 16;11(1):34
pubmed: 29246185
Glia. 2013 Apr;61(4):623-35
pubmed: 23339081
BMJ. 2006 Mar 4;332(7540):521-5
pubmed: 16428252
Psychiatry Res. 2017 Jan;247:172-181
pubmed: 27915167
Neuropsychopharmacology. 2011 Sep;36(10):1982-91
pubmed: 21654733
Brain Res. 1992 Aug 14;588(1):154-8
pubmed: 1356586
Sci Rep. 2017 Mar 03;7:42991
pubmed: 28256506
Biol Psychiatry. 2011 Nov 15;70(10):928-36
pubmed: 21907973
Physiol Genomics. 2012 Dec 18;44(24):1188-200
pubmed: 23110767
Psychoneuroendocrinology. 2019 Sep;107:148-159
pubmed: 31129488
Cell Mol Life Sci. 2019 Jul;76(14):2739-2760
pubmed: 31016348
Int J Neuropsychopharmacol. 2014 Dec 13;18(4):
pubmed: 25522420
BMC Syst Biol. 2011 Oct 13;5:162
pubmed: 21995951
Neurosci Biobehav Rev. 2015 Nov;58:79-91
pubmed: 26116544
Ann N Y Acad Sci. 2004 Dec;1032:1-7
pubmed: 15677391
Genes Brain Behav. 2017 Feb;16(2):223-232
pubmed: 27648526
Front Psychiatry. 2019 Jun 28;10:423
pubmed: 31316402
Mol Psychiatry. 2014 Jul;19(7):834-41
pubmed: 24419043
Neuroendocrinology. 1990 Jul;52(1):57-64
pubmed: 2118608
Rev Neurosci. 2014;25(6):785-804
pubmed: 25178904
Neuropsychopharmacology. 2016 Jan;41(1):1-2
pubmed: 26657948
Eur J Neurosci. 2021 Jan;53(2):402-415
pubmed: 33030232
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):5995-9
pubmed: 22474371
Stem Cells Int. 2017;2017:1719050
pubmed: 29081809
Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S186-95
pubmed: 19560279